Conclusion
LACI
AMI, EVENTS
This study confirmed previous findings of calculating a CMR-derived LACI for optimizing risk stratification of cardiovascular events and demonstrated its usability and prognostic value in patients following AMI. LACI was significantly associated with MACE in AMI patients at 1-year follow-up and enabled better risk stratification than sole LA or LV volume analyses especially in high-risk patients according to reduced LVEF. Simple calculation of LACI adds a further valuable parameter for the identification of patients at higher risk for MACE and can be easily implemented in clinical routine.